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Abstract
Objective—Trichotillomania/hair pulling disorder (HPD) and excoriation/skin picking disorder 
(SPD) are childhood-onset, body-focused repetitive behaviors that are thought to share genetic 
susceptibility and underlying pathophysiology with obsessive-compulsive disorder (OCD) and 
Tourette syndrome (TS). We sought to determine the prevalence of DSM-5 HPD and SPD in TS 
patients, and to identify clinical factors most associated with their co-morbidity with TS.
Method—Participants included 811 TS patients recruited from TS specialty clinics for a multi-
center genetic study. Patients were assessed using standardized, validated semi-structured 
interviews. HPD and SPD diagnoses were determined using a validated self-report questionnaire. 
HPD/SPD prevalence rates were calculated, and clinical predictors were evaluated using 
regression modeling.
Results—3.8% and 13.0% of TS patients met DSM-5 criteria for HPD and SPD, respectively. In 
univariable analyses, female sex, OCD, and both tic and obsessive-compulsive severity were 
among those associated with HPD and/or SPD. In multivariable analyses, only lifetime worst-ever 
motor tic severity remained significantly associated with HPD. Female sex, co-occurring OCD, 
ADHD and motor tic severity remained independently associated with SPD.
Conclusion—This is the first study to examine HPD and SPD prevalence in a TS sample using 
semi-structured diagnostic instruments. The prevalence of HPD and SPD in TS patients, and their 
association with increased tic severity and co-occurring OCD, suggests that clinicians should 
screen children with TS and related disorders for HPD/SPD, particularly in females and in those 
with co-occurring OCD. This study also helps set a foundation for subsequent research regarding 
HPD/SPD risk factors, pathophysiology, and treatment models.
Keywords
Trichotillomania/Hair Pulling Disorder; Excoriation Disorder/Skin Picking Disorder; Tourette 
syndrome; Obsessive-Compulsive Disorder; Body-Focused Repetitive Behaviors; tics
INTRODUCTION
Body-focused repetitive behaviors (BFRBs) are potentially debilitating, pathological 
repetitive behaviors that target one or more body regions, and include problematic hair 
pulling, skin picking, and nail biting [1–3]. Here, we focus on two BFRBs, trichotillomania/
hair pulling disorder (HPD) and excoriation/skin picking disorder (SPD), which are included 
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in the DSM-5 within the obsessive-compulsive related disorders (OCRD) chapter [4]. HPD 
and SPD are characterized by recurrent hair pulling (or skin picking) resulting in hair loss 
(or skin lesions), the inability to stop pulling/picking, and associated significant distress or 
functional impairment.
DSM-5 HPD is hypothesized to affect 1–2% of the population [4]; however, HPD prevalence 
has been difficult to characterize given the lack of large-scale epidemiological studies and 
the use of inconsistent diagnostic criteria across existing reports [5]. As such, HPD 
prevalence estimates have ranged from 0.6% for both sexes combined using strict DSM-III-
R criteria to 1.5% of males and 3.4% of females using less stringent criteria [6]. DSM-IV 
HPD prevalence is thought to be about 1% [5]. While the gender distribution of HPD in the 
community varies across studies, the clinical HPD population tends to be primarily female 
[5, 7].
SPD prevalence has been similarly challenging to estimate, given its changing definition 
over time and its absence in the DSM until the most recent version, DSM-5, published in 
2013 [4]. Prior to 2013, studies of non-clinical samples have reported prevalence rates 
ranging from 1.4–5.4% [8–10]; current DSM-5 estimates range as high as 7.7% [11]. As in 
HPD, SPD is also believed to affect more women than men [12].
Both HPD and SPD are typically early adolescent-onset conditions. While HPD age of onset 
is fairly uniform, usually occurring between ages 11–14 [7], SPD onset varies more 
substantially, with three reported peaks of onset: age<10, 13–15, and 30–45 [8]. HPD and 
SPD show increased co-morbidity with one another [7, 13, 14], and a large population-based 
twin study demonstrated that HPD and SPD have a significant proportion of shared 
heritability as well [14]. Both disorders also have shared heritability and presumably 
overlapping pathophysiology with OCD, and thus have been included as obsessive-
compulsive related disorders (OCRDs) in DSM-5 [14]. Like OCD, patients with HPD and/or 
SPD find it difficult to resist behaviors/rituals despite aversive consequences [5, 8]. OCD 
patients also tend to have elevated rates of HPD and SPD compared to controls, and these 
BFRBs occur more frequently in relatives of OCD probands than in relatives of controls 
[14–21].
However, the relationship between BFRBs and Tourette syndrome (TS) is less well 
understood. TS is a childhood-onset neuropsychiatric disorder characterized by multiple 
motor tics and at least one vocal tic present for at least one year in duration [4]. TS, BFRBs 
and OCD share multiple characteristics and etiological features, including repetitive, 
impulsive and compulsive behaviors, dysregulated habit formation, proposed overlapping 
pathophysiology attributed to frontostriatal dysfunction, and impaired inhibition of motor 
responses [2, 22, 23]. In fact, many researchers categorize TS as an OCRD for both research 
and clinical purposes, based on shared characteristics, genetic relationships, and 
psychobiological overlap [2, 15, 17, 23].
The few existing studies of TS and HPD have generally found increased HPD rates in TS 
patients, including one that examined DSM-IV-based HPD diagnoses and reported a rate of 
2.6% [3, 24, 25]. However, prior studies have been limited by the absence of formal 
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diagnostic instruments, and/or did not examine whether the higher rates of HPD in TS 
patients are seen only when OCD is also present, or whether there might be a more direct 
relationship between TS and HPD independent of OCD [2, 22, 26–28]. Even less is known 
about SPD in TS. Outside of increased rates of skin picking reported in a sample of OCD 
patients with tic disorders compared to OCD patients without tics, the prevalence of SPD in 
TS patients has not, to our knowledge, been examined [29].
Developing a better understanding of the relationship between BFRBs and TS has both 
potential diagnostic and treatment implications. If studies were to suggest a stronger 
association between TS and BFRBs compared to OCD and BFRBs, they might change how 
these repetitive disorders are taught, organized and conceptualized, especially given that 
BFRBs are currently characterized as OCRDs, separate from TS. An improved 
understanding of the clinical phenomenology of HPD and SPD may also help to generate 
hypotheses about the underlying pathophysiologic mechanisms of BFRBs and to guide 
future genetic, imaging and other etiological studies [30]. Clarifying these relationships 
could also impact treatment approaches, as OCD and TS respond to different 
pharmacological interventions (i.e. selective serotonin reuptake inhibitors in OCD, 
neuroleptics in TS).
Therefore, the goals of this study were to (1) characterize HPD and SPD in a TS sample, and 
(2) to determine which factors, if any, are associated with the presence of HPD or SPD in 
TS-affected patients. In particular, we were interested in whether BFRBs in TS could be 
attributed to co-occurring OCD, other co-morbidities or clinical factors; or conversely, 
whether the relationship might be more directly associated with TS. We hypothesized that 
(1) both HPD and SPD rates would be increased in TS patients compared to that in the 
general population and (2) that elevated HPD/SPD rates would be only partially explained 
by the presence of co-occurring OCD.
METHODS
Patients
Patients with DSM-IV-TR-defined TS (N=811) and data on hair pulling and skin picking 
behaviors were included in this study. Patients were recruited from TS specialty clinics in 
the US and Canada as part of a larger multi-site genetic study [31, 32]. All patients provided 
written informed consent (written assent was obtained for individuals <18 along with written 
parental consent). Patients <18 who completed the questionnaires typically did so with the 
assistance of their parents. Patients with existing diagnoses of developmental delay or 
intellectual disability were excluded. The study was approved by the relevant IRBs at all 
sites.
Diagnoses
Patients were assessed using a standardized, semi-structured instrument developed by the 
Tourette Association of America International Consortium for Genetics (TAAICG) 
(formerly known as the TSAICG), the Tic and Co-morbid Symptom (TICS) Inventory, 
which has previously been demonstrated to be valid and reliable for diagnoses of TS, OCD, 
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and attention deficit hyperactivity disorder (ADHD) [32, 33]. Interview questions included 
demographic information, tic and obsessive-compulsive severity scales and symptom 
checklists modified from the Yale Global Tic Severity Scale (YGTSS), the Yale-Brown 
Obsessive-Compulsive Scale (Y-BOCS), and the Swanson Nolan and Pelham Parent and 
Teacher Rating Scale for ADHD, version 4 (SNAP-IV) [34–36]. Clinical lifetime diagnoses 
of TS, OCD, and ADHD were determined by TS clinical research experts using a best-
estimate consensus approach [33]. Only patients who met DSM-IV-TR TS criteria, and had 
available HPD, SPD, OCD, and ADHD data were included in the analyses. Reliable 
information about medication status was not available.
Patients were assessed for lifetime HPD and SPD using a self-report screening questionnaire 
on Body-Focused Repetitive Behaviors (BFRBs) contained within the TICS Inventory 
(BFRB questionnaire; see Online Resource 1, Figure S1). This questionnaire was initially 
designed for genetic and family studies of childhood-onset OCD [18], and includes separate 
questions on a) lifetime presence of hair pulling and/or skin picking, b) the ability (or 
inability) to stop pulling hair/picking skin, c) whether these behaviors ever resulted in bald 
spots, noticeable hair loss, scabbing, or infections, d) the presence of tension and/or relief 
associated with completion of the behavior, and e) questions assessing age of onset, 
impairment, distress, and effects on important relationships. Though the questionnaire was 
developed prior to the advent of the DSM-5, it includes all criteria needed to establish both 
DSM-IV and DSM-5 diagnoses (Online Resource 1, Figure S1). We established the validity 
of the BFRB self-report questionnaire for determining DSM-5 HPD and SPD diagnoses 
using an independent sample of 78 HPD patients and 183 first-degree relatives of HPD 
patients recruited for HPD genetic and family studies [13]. For validating DSM-IV 
diagnoses, 97 HPD cases and 47 unaffected controls from the HPD family study were used 
(Online Resource 1). DSM-IV and DSM-5 HPD diagnoses were determined using a best-
estimate consensus approach by two independent raters using only the BFRB questionnaire 
(Online Resource 1). DSM-5 SPD diagnoses were assigned, as were “DSM-IV equivalent” 
SPD diagnoses based on previously published criteria to facilitate comparisons (Online 
Resource 1, Figure S2) [37]. Kappa coefficients comparing diagnoses derived from the 
BFRB questionnaire versus gold-standard diagnostic interviews were 0.93 and 0.77 for 
DSM-5 HPD and SPD, respectively; kappa coefficients for DSM-IV HPD and DSM-IV-
equivalent SPD were 0.85 and 0.91, respectively (Online Resource 1, Table S1).
Analyses
All statistical analyses were performed in Stata v12 (StataCorp, College Station, TX). 
Candidate HPD/SPD clinical predictors, selected based on the literature, included: age, sex, 
co-occurring OCD or ADHD, TS and OCD age of onset, family history of TS and/or OCD 
and worst-ever YGTSS and Y-BOCS scores. Univariable logistic regression was used to 
determine odds ratios and 95% confidence intervals (CI) for categorical and continuous 
predictor variables. Wilcoxon rank-sum tests were used to compare differences for non-
normally distributed continuous variables, including age at interview and ages of onset. 
Fisher’s exact test was used to examine differences in HPD/SPD prevalence rates among 
children (≤12), adolescents (13–17) and adults (≥18). Candidate predictors with p<0.10 in 
univariable analyses were considered for inclusion in the final multivariable regression 
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model. Age at time of interview was included in the final models to control for younger 
patients who had not yet passed through the BFRB developmental period of risk. For the 
final models, variables were considered to be independently associated with HPD and/or 
SPD at a threshold of p<0.05. All statistical tests were two-tailed. If more than one tic-
related severity score was associated with the outcome of interest, only the most highly 
associated score was included in the multivariable analyses to limit confounding. Similarly, 
to increase power, family history of TS and OCD was examined as a joint variable, since the 
number of subjects with a positive family history of each disorder separately was small, 
particularly in the HPD+ sample, and because prior data suggests that OCD in relatives of 
TS probands may arise from a genetic susceptibility for TS [38]. Co-linearity between all 
predictor variables was assessed in post-hoc analyses by calculating their variance inflation 
factors (VIFs). Variables with a VIF>10 were considered to be co-linear. When variables 
were found to be co-linear, the variable with the strongest univariate relationship with the 
outcome variable was used in multivariable calculations; all others were removed from the 
model.
RESULTS
Sample Characteristics
77% (n=628) of TS patients were male; the average age of TS onset was 6.1 years (SD 2.7) 
(Table 1). 53% (n=422) and 48% (n=372) met DSM-IV criteria for OCD and ADHD, 
respectively. 54% (n=425) of TS patients had a family history of OCD and/or TS. The 
average YGTSS total tic score was 31.4/50 (SD 8.3), consistent with moderately severe TS. 
Of those with OCD, the average Y-BOCS score was 23.9/40 (SD 7.2), consistent with 
moderately severe OCD.
2.6% (n=20) and 3.8% (n=29) of TS patients met DSM-IV and DSM-5 diagnostic criteria 
for HPD, respectively. Females had approximately twice the rate of HPD as males using 
either diagnostic criteria (6.4% vs. 3.0%, respectively, for DSM-5 HPD, (χ2(1)=4.3, 
p=0.04); 4.7% vs. 2.0% for DSM-IV-TR HPD (χ2(1)=3.7, p=0.05). The median age of HPD 
onset was 12.8 years (IQR, 7–16; Online Resource 1, Figure S3). When stratified by age of 
interview, 1.6% of children met DSM-5 criteria for HPD, compared to 3.5% of adolescents, 
and 6.4% of adults (p=0.01; Online Resource 1, Table S2). Similarly, comparing all children 
<18 to adults, 2% met DSM-5 criteria for HPD compared to 6.4% of adults (p=0.005) 
(Online Resource 1, Table S3).
13.0% (n=101) met DSM-5 criteria for SPD. As with HPD, females had approximately a 2-
fold increase in rates of DSM-5 SPD compared to males (19.7% vs. 11.1%, (χ2(1)=8.7, 
p=0.003). The mean age of SPD onset was 8.3 years (SD 3.7) (Online Resource 1, Figure 
S3). Age of onset between males and females did not differ for either HPD or SPD (Mann-
Whitney U Z=1.2, p=0.24 and t=0.02, p=0.98, respectively). Unlike HPD, there were no 
significant differences in SPD rates between children (10%), adolescents (15.8%) and adults 
(14.2%) (p=0.12) (Online Resource 1, Table S2), or between those ages <18 (12%) 
compared to those ≥18 (14%) (p=0.47) (Online Resource 1, Table S3). Of those with HPD, 
35% (n=9) of patients had SPD; of those with SPD, 9.4% (n=9) had HPD.
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HPD Univariable Analyses
In TS patients meeting DSM-5 HPD criteria, female sex, co-occurring SPD, higher YGTSS 
total tic score, higher YGTSS motor tic score, higher Y-BOCS total score, co-occurring 
OCD, and a family history of TS and/or OCD were associated with HPD at p≤0.10 (Table 
2). Given its stronger association with HPD in the univariable analyses, YGTSS motor tic 
score rather than YGTSS total tic score was included in the multivariable analysis.
HPD Multivariable Analysis
In the final multivariable model, only YGTSS motor score remained significantly associated 
with increased risk of HPD (14% increased risk for every 1 point increase in YGTSS motor 
tic severity; p=0.04) (Table 3). Females with TS had nearly twice the odds of co-occurring 
HPD compared to males, though this association did not surpass nominal significance 
(OR=1.97, 95%CI: 0.81–4.80, p=0.14) (Table 3). To examine whether these results might 
have been driven primarily by either the child or adult TS subgroups alone, we conducted a 
sensitivity analysis by stratifying the sample into children and adults and repeating the 
multivariable regression analyses in each age group separately. The results of these stratified 
analyses were generally consistent across both pediatric and adult subgroups (Online 
Resource 1, Table S4).
SPD Univariable Analyses
In the univariable analyses, female sex, increased YGTSS scores, co-occurring OCD, OCD 
age of onset, increased Y-BOCS score, co-occurring HPD, co-occurring ADHD, a positive 
family history of HPD, and a positive family history of either TS or OCD met pre-specified 
criteria (p<0.10) for inclusion in the multivariable model (Table 4).
SPD Multivariable Analysis
In the SPD multivariable analysis, female sex, co-occurring OCD, ADHD, YGTSS motor 
score, and a positive family history of either TS or OCD all remained significantly 
associated with increased SPD risk in TS patients (Table 5). To examine whether these 
results might have been driven primarily by either the child or adult TS subgroups alone, we 
conducted a sensitivity analysis by stratifying the sample into children and adults and 
repeating the multivariable regression analyses in each age group separately. The results of 
these stratified analyses were generally consistent across both pediatric and adult subgroups 
(Online Resource 1, Table S4).
Because OCD age of onset and Y-BOCS score are dependent on positive OCD diagnoses, 
and would thus be collinear with OCD in a multivariable regression, they were not included 
in the final SPD multivariable regression model. However, a secondary analysis restricted to 
TS patients with co-occurring OCD demonstrated that OCD age of onset was also an 
independent predictor of SPD, with younger age of onset associated with higher risk 
(OR=0.86, 95% CI: 0.78–0.95, p=0.004), while Y-BOCS score was not (OR=1.02, 95% CI: 
0.98–1.07, p=0.25) (Online Resource 1, Table S6).
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DISCUSSION
The primary aims of this study were to determine prevalence rates and clinical predictors of 
HPD and SPD in patients with Tourette syndrome (TS). We sought to clarify whether the 
occurrence of these BFRBs in TS might be mediated by a shared co-morbidity with OCD or 
whether BFRBs may be associated with TS independent of co-occurring OCD. This study 
expands on the current literature in two ways: 1) the use of a structured, systematic 
assessment of BFRBs in a large sample of well-characterized TS patients using a validated, 
brief self-report questionnaire; 2) the examination of SPD, which to date has not been 
studied in TS.
In this TS sample, 3.8% of patients met DSM-5 HPD criteria. While the population 
prevalence of DSM-5 HPD has not yet been established, preliminary estimates range from 
1–2%, suggesting that our sample had twice the presumed population prevalence of HPD 
[4]. The DSM-IV HPD rate of 2.6% observed here in TS patients is also more than twice the 
reported DSM-IV HPD population prevalence of 1% [5], and comparable to the estimate of 
2.6% from an international TS clinical registry [3]. Although previously reported rates are 
more variable for SPD, the 13% SPD prevalence rate found in this study represents a nearly 
two-fold increase over the highest reported estimates in non-clinical samples based on 
DSM-5 criteria (7.7%) [11], and a two-to-nine-fold increase over the more commonly 
accepted population rates of 1.4–5.4%. Given that HPD/SPD rates were higher in adolescent 
and adult TS patients than in children (Online Resource 1, Table S2; Figure S3), consistent 
with prior reports of an HPD and SPD peak onset in early adolescence [7, 8], these estimates 
may be conservative. Of note, prior studies systematically assessing OCD patients and 
controls for DSM-IV HPD and DSM-IV-equivalent SPD [37] using the same BFRB 
questionnaire found similar, though notably higher, rates of HPD and SPD in OCD patients 
(HPD: 11% of OCD patients vs. 1% controls; SPD: 31% OCD patients vs. 6% controls) [18, 
19, 39]. Both HPD and TS are also found more frequently in early-onset than in later-onset 
OCD [40, 41]. These data suggest that TS may have a similar biological (possibly genetic) 
relationship with HPD and SPD as previously demonstrated for HPD/SPD and OCD [14]. In 
this context, it is also worth noting that both tics and BFRBs can be influenced by internal 
(e.g. anxiety, excitement) and external (e.g. homework, classroom) environmental states [7].
Prior studies have repeatedly demonstrated that HPD and SPD co-occur more frequently 
than expected by chance [7]. Heritability analyses in a large UK twin sample found that, in 
addition to a genetic liability factor that was shared across all studied OCRDs (HPD, SPD, 
OCD, hoarding disorder and body dysmorphic disorder), a second genetic liability factor 
loaded exclusively on HPD and SPD [14]. Findings in our sample, where 35% of patients 
with HPD had SPD, and 9.4% with SPD had HPD, are consistent with these findings, and 
provide further support for grouping HPD and SPD together as related disorders in DSM-5. 
The significant association between SPD and family history of OCD or TS also supports the 
notion of shared heritability across these BFRBs, OCD, and TS [14, 18, 42].
As seen in previous clinical samples, females in the current study were twice as likely as 
males to have HPD and/or SPD, though the relationship between female sex and HPD was 
not significant in the multivariable analysis. Given the small number of patients that met 
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DSM-5 HPD criteria, and the 3:1 ratio of males to females (as would be expected in a 
clinical TS population) [3], our sample is likely underpowered to detect significant 
differences by sex in multivariable models. Recent studies have also proposed that the 
previously observed female predominance in HPD patients might be a function of treatment-
seeking bias, rather than an actual increased female-to-male prevalence in the general 
population [7]. Other studies have reported that childhood-onset HPD may be more sex 
equal, and that male hair-pullers tend to have more tics than females [17, 43]. However, as 
the patients in our study were not ascertained based on seeking treatment for HPD, female 
sex appears to represent a major risk factor for HPD and SPD in TS patients.
While female sex had a consistent relationship with both HPD and SPD, patterns of 
association with other clinical variables differed between the two disorders in our sample. In 
the multivariable analyses, YGTSS motor tic score was the only predictor significantly 
associated with both higher HPD and SPD rates. In contrast, co-occurring OCD, younger 
age of OCD onset, and ADHD were all significantly associated with SPD, but not HPD. The 
strongest SPD predictor was OCD: TS patients with co-occurring OCD had four times the 
odds of meeting DSM-5 SPD criteria compared to those without OCD. Earlier OCD onset 
has also been associated with co-occurring BFRBs in OCD patients [2, 16]. These findings 
are consistent with prior studies that found reciprocal increases of SPD rates in OCD 
samples and OCD rates in SPD samples, and suggests that at least part of the increased SPD 
prevalence seen in TS is accounted for by co-occurring OCD [18, 20]. The fact that co-
occurring OCD and earlier age of OCD onset were the two most strongly associated 
predictors of SPD (vs. HPD) in our TS sample suggests that SPD may be more directly 
related to the presence of OCD than to TS (Tables 5 and S3). It will therefore be interesting 
to see if future studies demonstrate a closer relationship between SPD and OCD compared 
to HPD and OCD, especially as SPD has shown some treatment response to SSRIs (a gold-
standard OCD medication) [48], whereas HPD is typically less responsive [49].
Our findings are also consistent with the hypothesis that HPD may be more closely related 
to tic disorders (or tic disorders with co-occurring OCD) than to OCD alone [26, 44]. 
Despite the previously reported association between HPD and OCD [19], we did not find 
significantly elevated rates of OCD in TS patients with HPD. While the small number of 
HPD+ patients in our sample limits the power to detect predictors of co-morbid HPD, 
Coffey et al. also observed that patients with TS and/or TS+OCD had higher rates of HPD 
than those with OCD alone, leading her to hypothesize that HPD may be a TS-spectrum 
disorder [26]. Additionally, Rozenman et al recently found that patients with pediatric HPD 
and pediatric tic disorders had more similar anxiety and depression symptom profiles 
compared to pediatric OCD patients [30]. The observed association between HPD and 
increased motor tic severity in the current study suggests that co-occurring HPD in TS 
patients may be indicative of a higher TS disease burden. Prior work from our group and 
others has also demonstrated that increased tic severity is correlated with the presence of co-
morbidity in general [23, 26, 45]. However, larger samples in future studies will be needed 
to compare and contrast the differences between HPD and SPD and their clinical and 
etiological relationships to TS.
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SPD in this TS sample was also associated with ADHD. Previous OCD studies have shown 
both ADHD and SPD to be elevated in OCD patients with tics compared to those with OCD 
alone [2, 26, 29]. These results parallel prior work suggesting that individuals with BFRBs 
have problems with impulse control, similar to findings seen in ADHD [17, 22]. Given that 
other clinical studies have identified impaired impulse control in patients with these 
disorders individually (BFRBs, ADHD, and TS [46]), one might hypothesize that TS, 
ADHD and BFRBs have related dysfunction in cognitive control circuitry, which might be 
explained by a shared genetic susceptibility. Additional research examining neurocognitive 
profiles and comparing imaging/genetic analyses will continue to help elucidate the 
comparable and contrasting factors between tics, BFRBs, impulsivity and compulsions [47]. 
Although this study has many strengths, including the large sample size, the use of validated, 
standardized diagnostic assessments, and the availability of rich clinical data, it also has 
limitations. First, given the small number of subjects with HPD (n=29) compared to those 
with SPD (n=101), there was limited statistical power to detect significant predictors in HPD
+ subjects, which reduced the ability to make definitive comparisons between HPD and SPD 
and their potential relationship(s) to TS and co-occurring conditions. Second, while this TS 
sample is the largest studied to date using formal diagnostic instruments [3, 25], the 3–4:1 
M:F ratio led to a relative dearth of female patients. Many patients were also interviewed 
prior to the peak age of HPD/SPD onset, which typically occurs in early adolescence [7]; 
thus, some patients may not have yet developed HPD or SPD. However, this potential 
confound should under-estimate HPD/SPD prevalence, and we controlled for this problem to 
the degree possible by including age-at-assessment in the regression analyses. In addition, 
although we validated the BFRB questionnaire against gold-standard structured diagnostic 
interviews, self-reports in children/adolescents may be less accurate than those of adults. 
However, pediatric subjects typically completed the BFRB questionnaire with parental 
assistance, which in our experience improves the accuracy of responses. Because patients 
were recruited from major medical centers across North America, this research-based patient 
population may be subject to referral bias, and be more symptomatic than those in 
community-based samples. We know from Scharf et al [50] that rates of co-occurring OCD 
and ADHD in a TS population-based study tend to be lower than those found in clinical 
samples. Therefore, one has to be cautious about generalizing these findings to the TS 
population as a whole, though this study’s subjects are likely more akin to TS patients one 
would see and assess for HPD/SPD in a clinical setting. In the future, it would be helpful to 
conduct similar analyses in community/non-treatment seeking samples. Another limitation is 
that SPD and HPD may also be associated with other clinical characteristics not assessed in 
our sample, including co-occurring autism spectrum, mood and/or anxiety disorders. It 
would be very useful to study the associations of those syndromes with HPD and SPD as 
well in future studies. Finally, given that our results were based on retrospective data 
analyses, our findings are correlational and speculative in nature, and therefore need to be 
tested more formally in the future.
Despite these potential limitations, this work provides important information for clinicians 
and researchers. Clinically, the elevated rates of HPD and SPD, particularly among females 
and those with OCD, suggest that these disorders should be included in routine clinical 
assessments of TS patients. The association of OCD and ADHD, especially with SPD in our 
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sample, and the early age of onset for this disorder, further suggests that these assessments 
should begin in early childhood, and are particularly important for children who show 
evidence of ADHD, as, of the three disorders, ADHD tends to have the earliest onset. In 
addition, the questionnaires used in this study are brief, making them feasible for use in a 
busy clinic, and we have demonstrated that they are valid for this population ranging from 
children to adults. From a research perspective, given the new diagnostic criteria and 
categorization schema in DSM-5 and the recent findings of genetic overlap, it will be 
important to further delineate the clinical and etiological relationships of HPD, SPD and 
other BFRBs and TS, OCD and related disorders. Raising awareness of the co-occurrence of 
HPD and SPD in TS may also improve screening for these disorders and help guide patients 
to available treatment options and relief of suffering from these impairing conditions.
Supplementary Material
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Acknowledgments
The authors thank the families, patients, and control volunteers who participated in this research, and the members 
of the Tourette Association for America International Genetics Consortium. This work was supported by the 
National Institutes of Health, grant numbers R01MH096767 (PI: Carol Mathews), U01NS040024 (PI: David Pauls/
Jeremiah Scharf), K23MH085057 (PI: Jeremiah Scharf), and grants from the TLC Foundation for Body-Focused 
Repetitive Behaviors and from the Tourette Association of America.
References
1. McGuire JF, Kugler BB, Park JM, Horng B, Lewin AB, Murphy TK, Storch EA. Evidence-based 
assessment of compulsive skin picking, chronic tic disorders and trichotillomania in children. Child 
psychiatry and human development. 2012; 43(6):855–883. DOI: 10.1007/s10578-012-0300-7 
[PubMed: 22488574] 
2. Ferrao YA, Miguel E, Stein DJ. Tourette's syndrome, trichotillomania, and obsessive-compulsive 
disorder: how closely are they related? Psychiatry Res. 2009; 170(1):32–42. DOI: 10.1016/
j.psychres.2008.06.008 [PubMed: 19801170] 
3. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international 
perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries. Dev 
Med Child Neurol. 2000; 42(7):436–447. [PubMed: 10972415] 
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5. 
Washington, DC: 2013. 
5. Duke DC, Keeley ML, Geffken GR, Storch EA. Trichotillomania: A current review. Clinical 
psychology review. 2010; 30(2):181–193. DOI: 10.1016/j.cpr.2009.10.008 [PubMed: 19926375] 
6. Christenson GA, Pyle RL, Mitchell JE. Estimated lifetime prevalence of trichotillomania in college 
students. J Clin Psychiatry. 1991; 52(10):415–417. [PubMed: 1938977] 
7. Snorrason I, Belleau EL, Woods DW. How related are hair pulling disorder (trichotillomania) and 
skin picking disorder? A review of evidence for comorbidity, similarities and shared etiology. 
Clinical psychology review. 2012; 32(7):618–629. DOI: 10.1016/j.cpr.2012.05.008 [PubMed: 
22917741] 
8. Grant JE, Odlaug BL, Chamberlain SR, Keuthen NJ, Lochner C, Stein DJ. Skin picking disorder. 
Am J Psychiatry. 2012; 169(11):1143–1149. DOI: 10.1176/appi.ajp.2012.12040508 [PubMed: 
23128921] 
9. Hayes SL, Storch EA, Berlanga L. Skin picking behaviors: An examination of the prevalence and 
severity in a community sample. Journal of anxiety disorders. 2009; 23(3):314–319. DOI: 10.1016/
j.janxdis.2009.01.008 [PubMed: 19223150] 
Greenberg et al. Page 11
Eur Child Adolesc Psychiatry. Author manuscript; available in PMC 2019 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
10. Keuthen NJ, Koran LM, Aboujaoude E, Large MD, Serpe RT. The prevalence of pathologic skin 
picking in US adults. Comprehensive psychiatry. 2010; 51(2):183–186. DOI: 10.1016/
j.comppsych.2009.04.003 [PubMed: 20152300] 
11. Prochwicz K, Kaluzna-Wielobob A, Klosowska J. Skin picking in a non-clinical sample of young 
Polish adults. Prevalence and characteristics. Comprehensive psychiatry. 2016; 71:77–85. DOI: 
10.1016/j.comppsych.2016.08.013 [PubMed: 27639125] 
12. Wilhelm S, Keuthen NJ, Deckersbach T, Engelhard IM, Forker AE, Baer L, O'Sullivan RL, Jenike 
MA. Self-injurious skin picking: clinical characteristics and comorbidity. J Clin Psychiatry. 1999; 
60(7):454–459. [PubMed: 10453800] 
13. Keuthen NJ, Altenburger EM, Pauls D. A family study of trichotillomania and chronic hair pulling. 
Am J Med Genet B Neuropsychiatr Genet. 2014; 165B(2):167–174. DOI: 10.1002/ajmg.b.32218 
[PubMed: 24415254] 
14. Monzani B, Rijsdijk F, Harris J, Mataix-Cols D. The structure of genetic and environmental risk 
factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders. 
JAMA Psychiatry. 2014; 71(2):182–189. DOI: 10.1001/jamapsychiatry.2013.3524 [PubMed: 
24369376] 
15. Lochner C, Stein DJ. Obsessive-compulsive spectrum disorders in obsessive-compulsive disorder 
and other anxiety disorders. Psychopathology. 2010; 43(6):389–396. DOI: 10.1159/000321070 
[PubMed: 20847586] 
16. Lovato L, Ferrao YA, Stein DJ, Shavitt RG, Fontenelle LF, Vivan A, Miguel EC, Cordioli AV. Skin 
picking and trichotillomania in adults with obsessive-compulsive disorder. Comprehensive 
psychiatry. 2012; 53(5):562–568. DOI: 10.1016/j.comppsych.2011.06.008 [PubMed: 22014580] 
17. Stein DJ, Grant JE, Franklin ME, Keuthen N, Lochner C, Singer HS, Woods DW. Trichotillomania 
(hair pulling disorder), skin picking disorder, and stereotypic movement disorder: toward DSM-V. 
Depression and anxiety. 2010; 27(6):611–626. DOI: 10.1002/da.20700 [PubMed: 20533371] 
18. Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Saric R, Liang KY, Cullen BA, Grados MA, Nestadt 
G. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from 
a family study. Biol Psychiatry. 2000; 48(4):287–293. [PubMed: 10960159] 
19. Bienvenu OJ, Samuels JF, Wuyek LA, Liang KY, Wang Y, Grados MA, Cullen BA, Riddle MA, 
Greenberg BD, Rasmussen SA, Fyer AJ, Pinto A, Rauch SL, Pauls DL, McCracken JT, Piacentini 
J, Murphy DL, Knowles JA, Nestadt G. Is obsessive-compulsive disorder an anxiety disorder, and 
what, if any, are spectrum conditions? A family study perspective. Psychol Med. 2012; 42(1):1–13. 
DOI: 10.1017/S0033291711000742 [PubMed: 21733222] 
20. Cullen BA, Samuels JF, Bienvenu OJ, Grados M, Hoehn-Saric R, Hahn J, Liang KY, Wellen D, 
Dees M, Riddle MA, Nestadt G. The relationship of pathologic skin picking to obsessive-
compulsive disorder. J Nerv Ment Dis. 2001; 189(3):193–195. [PubMed: 11277358] 
21. Lenane MC, Swedo SE, Rapoport JL, Leonard H, Sceery W, Guroff JJ. Rates of Obsessive 
Compulsive Disorder in first degree relatives of patients with trichotillomania: a research note. J 
Child Psychol Psychiatry. 1992; 33(5):925–933. [PubMed: 1634595] 
22. Flessner CA, Knopik VS, McGeary J. Hair pulling disorder (trichotillomania): genes, 
neurobiology, and a model for understanding impulsivity and compulsivity. Psychiatry Res. 2012; 
199(3):151–158. DOI: 10.1016/j.psychres.2012.03.039 [PubMed: 22537722] 
23. Hirschtritt ME, Lee PC, Pauls DL, Dion Y, Grados MA, Illmann C, King RA, Sandor P, McMahon 
WM, Lyon GJ, Cath DC, Kurlan R, Robertson MM, Osiecki L, Scharf JM, Mathews CA. Lifetime 
prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette 
syndrome. JAMA Psychiatry. 2015; 72(4):325–333. DOI: 10.1001/jamapsychiatry.2014.2650 
[PubMed: 25671412] 
24. Frank MC, Piedad J, Rickards H, Cavanna AE. The role of impulse control disorders in Tourette 
syndrome: an exploratory study. Journal of the neurological sciences. 2011; 310(1–2):276–278. 
DOI: 10.1016/j.jns.2011.06.032 [PubMed: 21741055] 
25. Janik P, Kalbarczyk A, Sitek M. Clinical analysis of Gilles de la Tourette syndrome based on 126 
cases. Neurologia i neurochirurgia polska. 2007; 41(5):381–387. [PubMed: 18033637] 
26. Coffey BJ, Miguel EC, Biederman J, Baer L, Rauch SL, O'Sullivan RL, Savage CR, Phillips K, 
Borgman A, Green-Leibovitz MI, Moore E, Park KS, Jenike MA. Tourette's disorder with and 
Greenberg et al. Page 12
Eur Child Adolesc Psychiatry. Author manuscript; available in PMC 2019 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
without obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis. 1998; 
186(4):201–206. [PubMed: 9569887] 
27. Diniz JB, Rosario-Campos MC, Hounie AG, Curi M, Shavitt RG, Lopes AC, Miguel EC. Chronic 
tics and Tourette syndrome in patients with obsessive-compulsive disorder. J Psychiatr Res. 2006; 
40(6):487–493. DOI: 10.1016/j.jpsychires.2005.09.002 [PubMed: 16289552] 
28. Petter T, Richter MA, Sandor P. Clinical features distinguishing patients with Tourette's syndrome 
and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics. 
J Clin Psychiatry. 1998; 59(9):456–459. [PubMed: 9771815] 
29. Gomes de Alvarenga P, de Mathis MA, Dominguez Alves AC, do Rosario MC, Fossaluza V, 
Hounie AG, Miguel EC, Rodrigues Torres A. Clinical features of tic-related obsessive-compulsive 
disorder: results from a large multicenter study. CNS spectrums. 2012; 17(2):87–93. DOI: 
10.1017/S1092852912000491 [PubMed: 22789066] 
30. Rozenman M, Peris TS, Gonzalez A, Piacentini J. Clinical Characteristics of Pediatric 
Trichotillomania: Comparisons with Obsessive-Compulsive and Tic Disorders. Child psychiatry 
and human development. 2016; 47(1):124–132. DOI: 10.1007/s10578-015-0550-2 [PubMed: 
25894516] 
31. Scharf JM, Yu D, Mathews CA, Neale BM, Stewart SE, Fagerness JA, Evans P, Gamazon E, 
Edlund CK, Service SK, Tikhomirov A, Osiecki L, Illmann C, Pluzhnikov A, Konkashbaev A, 
Davis LK, Han B, Crane J, Moorjani P, Crenshaw AT, Parkin MA, Reus VI, Lowe TL, Rangel-
Lugo M, Chouinard S, Dion Y, Girard S, Cath DC, Smit JH, King RA, Fernandez TV, Leckman JF, 
Kidd KK, Kidd JR, Pakstis AJ, State MW, Herrera LD, Romero R, Fournier E, Sandor P, Barr CL, 
Phan N, Gross-Tsur V, Benarroch F, Pollak Y, Budman CL, Bruun RD, Erenberg G, Naarden AL, 
Lee PC, Weiss N, Kremeyer B, Berrio GB, Campbell DD, Cardona Silgado JC, Ochoa WC, Mesa 
Restrepo SC, Muller H, Valencia Duarte AV, Lyon GJ, Leppert M, Morgan J, Weiss R, Grados 
MA, Anderson K, Davarya S, Singer H, Walkup J, Jankovic J, Tischfield JA, Heiman GA, Gilbert 
DL, Hoekstra PJ, Robertson MM, Kurlan R, Liu C, Gibbs JR, Singleton A, Hardy J, Strengman E, 
Ophoff RA, Wagner M, Moessner R, Mirel DB, Posthuma D, Sabatti C, Eskin E, Conti DV, 
Knowles JA, Ruiz-Linares A, Rouleau GA, Purcell S, Heutink P, Oostra BA, McMahon WM, 
Freimer NB, Cox NJ, Pauls DL. Genome-wide association study of Tourette's syndrome. Mol 
Psychiatry. 2013; 18(6):721–728. DOI: 10.1038/mp.2012.69 [PubMed: 22889924] 
32. TSAICG. Genome scan for Tourette disorder in affected-sibling-pair and multigenerational 
families. Am J Hum Genet. 2007; 80(2):265–272. [PubMed: 17304708] 
33. Darrow SM, Illmann C, Gauvin C, Osiecki L, Egan CA, Greenberg E, Eckfield M, Hirschtritt ME, 
Pauls DL, Batterson JR, Berlin CM, Malaty IA, Woods DW, Scharf JM, Mathews CA. Web-based 
phenotyping for Tourette Syndrome: Reliability of common co-morbid diagnoses. Psychiatry Res. 
2015; 228(3):816–825. [PubMed: 26054936] 
34. Bussing R, Fernandez M, Harwood M, Wei H, Garvan CW, Eyberg SM, Swanson JM. Parent and 
teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms: psychometric 
properties and normative ratings from a school district sample. Assessment. 2008; 15(3):317–328. 
DOI: 10.1177/1073191107313888 [PubMed: 18310593] 
35. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The 
Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989; 46(11):1012–
1016. [PubMed: 2510699] 
36. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. The Yale Global 
Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child 
Adolesc Psychiatry. 1989; 28(4):566–573. [PubMed: 2768151] 
37. Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. Clinical features, proposed 
diagnostic criteria, epidemiology and approaches to treatment. CNS drugs. 2001; 15(5):351–359. 
[PubMed: 11475941] 
38. Pauls DL, Raymond CL, Stevenson JM, Leckman JF. A family study of Gilles de la Tourette 
syndrome. Am J Hum Genet. 1991; 48(1):154–163. [PubMed: 1985456] 
39. Bienvenu OJ, Wang Y, Shugart YY, Welch JM, Grados MA, Fyer AJ, Rauch SL, McCracken JT, 
Rasmussen SA, Murphy DL, Cullen B, Valle D, Hoehn-Saric R, Greenberg BD, Pinto A, Knowles 
JA, Piacentini J, Pauls DL, Liang KY, Willour VL, Riddle M, Samuels JF, Feng G, Nestadt G. 
Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study. 
Greenberg et al. Page 13
Eur Child Adolesc Psychiatry. Author manuscript; available in PMC 2019 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Am J Med Genet B Neuropsychiatr Genet. 2009; 150B(5):710–720. DOI: 10.1002/ajmg.b.30897 
[PubMed: 19051237] 
40. Hemmings SM, Kinnear CJ, Lochner C, Niehaus DJ, Knowles JA, Moolman-Smook JC, Corfield 
VA, Stein DJ. Early- versus late-onset obsessive-compulsive disorder: investigating genetic and 
clinical correlates. Psychiatry Res. 2004; 128(2):175–182. DOI: 10.1016/j.psychres.2004.05.007 
[PubMed: 15488960] 
41. Grados MA, Riddle MA, Samuels JF, Liang KY, Hoehn-Saric R, Bienvenu OJ, Walkup JT, Song D, 
Nestadt G. The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: 
the Hopkins OCD family study. Biol Psychiatry. 2001; 50(8):559–565. [PubMed: 11690590] 
42. Mathews CA, Grados MA. Familiality of Tourette syndrome, obsessive-compulsive disorder, and 
attention-deficit/hyperactivity disorder: heritability analysis in a large sib-pair sample. J Am Acad 
Child Adolesc Psychiatry. 2011; 50(1):46–54. [PubMed: 21156269] 
43. Lochner C, Seedat S, Stein DJ. Chronic hair-pulling: phenomenology-based subtypes. Journal of 
anxiety disorders. 2010; 24(2):196–202. DOI: 10.1016/j.janxdis.2009.10.008 [PubMed: 19932593] 
44. Swedo SE, Lenane MC, Leonard HL. Long-term treatment of trichotillomania (hair pulling). The 
New England journal of medicine. 1993; 329(2):141–142. DOI: 10.1056/NEJM199307083290220 
[PubMed: 8510704] 
45. Coffey BJ, Biederman J, Smoller JW, Geller DA, Sarin P, Schwartz S, Kim GS. Anxiety disorders 
and tic severity in juveniles with Tourette's disorder. J Am Acad Child Adolesc Psychiatry. 2000; 
39(5):562–568. [PubMed: 10802973] 
46. Morand-Beaulieu S, Grot S, Lavoie J, Leclerc JB, Luck D, Lavoie ME. The puzzling question of 
inhibitory control in Tourette syndrome: A meta-analysis. Neurosci Biobehav Rev. 2017; 80:240–
262. DOI: 10.1016/j.neubiorev.2017.05.006 [PubMed: 28502600] 
47. Jahanshahi M, Obeso I, Rothwell JC, Obeso JA. A fronto-striato-subthalamic-pallidal network for 
goal- directed and habitual inhibition. Nature reviews Neuroscience. 2015; 16(12):719–732. DOI: 
10.1038/nrn4038 [PubMed: 26530468] 
48. Lochner C, Roos A, Stein DJ. Excoriation (skin-picking) disorder: a systematic review of treatment 
options. Neuropsychiatric disease and treatment. 2017; 13:1867–1872. DOI: 10.2147/
NDT.S121138 [PubMed: 28761349] 
49. Bloch MH, Landeros-Weisenberger A, Dombrowski P, Kelmendi B, Wegner R, Nudel J, Pittenger 
C, Leckman JF, Coric V. Systematic review: pharmacological and behavioral treatment for 
trichotillomania. Biol Psychiatry. 2007; 62(8):839–846. DOI: 10.1016/j.biopsych.2007.05.019 
[PubMed: 17727824] 
50. Scharf JM, Miller LL, Mathews CA, Ben-Shlomo Y. Prevalence of Tourette syndrome and chronic 
tics in the population-based Avon longitudinal study of parents and children cohort. J Am Acad 
Child Adolesc Psychiatry. 2012; 51(2):192–201. e195. DOI: 10.1016/j.jaac.2011.11.004 [PubMed: 
22265365] 
Greenberg et al. Page 14
Eur Child Adolesc Psychiatry. Author manuscript; available in PMC 2019 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Greenberg et al. Page 15
Ta
bl
e 
1
St
ud
y 
sa
m
pl
e 
ch
ar
ac
te
ris
tic
s s
tra
tif
ie
d 
by
 se
x
 (N
=8
11
)
C
at
eg
or
ic
al
 M
ea
su
re
s
n
 (%
)
M
al
e 
(%
)
Fe
m
a
le
 (%
)
χ2
p-
va
lu
e
N
um
be
r o
f p
at
ie
nt
s
81
1 
(10
0%
)
62
8 
(77
%)
18
3 
(23
%)
O
CD
42
2 
(53
%)
33
2 
(54
%)
90
 (5
1%
)
0.
65
0.
42
A
D
H
D
37
2 
(48
%)
31
5 
(53
%)
57
 (3
2%
)
22
.2
<
0.
00
1
Fa
m
ily
 h
ist
or
y 
of
 T
S 
or
 O
CD
42
5 
(54
%)
31
9 
(52
%)
10
6 
(59
%)
2.
23
0.
13
Fa
m
ily
 h
ist
or
y 
TS
20
3 
(26
%)
14
7 
(24
%)
56
 (3
0%
)
3.
51
0.
06
 
Fa
m
ily
 h
ist
or
y 
of
 O
CD
34
9 
(44
%)
26
7 
(44
%)
82
 (4
5%
)
0.
16
0.
69
 
Fa
m
ily
 h
ist
or
y 
of
 H
PD
52
 (6
.6%
)
41
 (6
.7%
)
11
 (6
.1%
)
0.
09
0.
78
C
on
tin
uo
us
 M
ea
su
re
s
M
ea
n 
(S
D)
M
al
e 
M
ea
n 
(S
D)
Fe
m
a
le
 M
ea
n 
(S
D)
Z
p-
va
lu
e
TS
 a
ge
 o
f o
ns
et
 (y
ea
rs)
6.
1 
(2.
7)
6.
0 
(2.
6)
6.
5 
(3.
1)
1.
51
0.
13
O
CD
 a
ge
 o
f o
ns
et
 (y
ea
rs)
7.
1 
(3.
7)
7.
0 
(3.
7)
7.
5 
(3.
5)
1.
51
0.
13
A
ge
 a
t i
nt
er
vi
ew
 (y
ea
rs)
18
.8
 (1
3.5
)
18
.1
 (1
3.0
)
21
.3
 (1
4.8
)
3.
01
0.
00
3
Y
G
TS
S 
To
ta
l t
ic
 sc
or
ea
 
(0–
50
)
31
.4
 (8
.3)
31
.5
 (8
.2)
31
.0
 (8
.6)
1.
12
0.
26
Y
G
TS
S 
M
ot
or
 ti
c 
sc
or
ea
 
(0–
25
)
17
.5
 (4
.3)
17
.6
 (4
.2)
17
.4
 (4
.3)
0.
34
0.
73
Y
G
TS
S 
Ph
on
ic
 ti
c 
sc
or
ea
 
(0–
25
)
13
.9
 (5
.3)
14
.0
 (5
.2)
13
.5
 (5
.6)
1.
39
0.
17
Y-
B
O
CS
 T
o
ta
l s
co
re
a  
(0–
40
)
23
.8
 (7
.2)
23
.6
 (7
.0)
24
.8
 (7
.8)
−
1.
25
0.
21
TS
=T
o
u
re
tte
 s
yn
dr
om
e;
 O
CD
=o
bs
es
siv
e-
co
m
pu
lsi
v
e 
di
so
rd
er
; A
D
H
D
=a
tte
nt
io
n-
de
fic
it/
hy
pe
ra
ct
iv
ity
 d
iso
rd
er
; H
PD
=H
ai
r-p
ul
lin
g 
di
so
rd
er
; Y
G
TS
S=
Ya
le
 G
lo
ba
l T
ic
 S
ev
er
ity
 S
ca
le
; Y
-
B
O
CS
=Y
al
e-
Br
ow
n
 
O
bs
es
siv
e-
Co
m
pu
lsi
v
e 
Sc
al
e;
 S
D
=s
ta
nd
ar
d 
de
v
ia
tio
n;
a l
ife
tim
e 
w
o
rs
t-
ev
er
 s
co
re
s
Eur Child Adolesc Psychiatry. Author manuscript; available in PMC 2019 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Greenberg et al. Page 16
Ta
bl
e 
2
U
ni
v
ar
ia
bl
e 
pr
ed
ic
to
rs
 o
f c
o-
oc
cu
rri
ng
 H
ai
r P
ul
lin
g 
D
iso
rd
er
 (H
PD
) i
n T
S p
ati
en
ts
Pr
ed
ic
to
r
n
 (%
)
O
R
 (9
5%
 C
I)
SE
z
p-
va
lu
e
Fe
m
al
e 
Se
x
11
 (3
8)
2.
21
 (1
.02
–4
.78
)
0.
87
2.
02
0.
04
O
CD
19
 (7
0)
2.
16
 (0
.94
–5
.01
)
0.
93
1.
80
0.
07
A
D
H
D
11
 (4
6)
0.
94
 (0
.42
–2
.13
)
0.
39
−
0.
14
0.
89
SP
D
9 
(35
)
3.
89
 (1
.68
–9
.01
)
1.
67
3.
18
0.
00
1
Fa
m
ily
 h
ist
or
y 
of
 T
S 
or
 O
CD
19
 (7
0)
2.
09
 (0
.90
–4
.83
)
0.
89
1.
72
0.
08
 
Fa
m
ily
 h
ist
or
y 
of
 T
S
8 
(30
)
1.
25
 (0
.54
–2
.91
)
0.
54
0.
52
0.
60
 
Fa
m
ily
 h
ist
or
y 
of
 O
CD
16
 (5
9)
1.
88
 (0
.86
–4
.10
)
0.
75
1.
58
0.
12
Fa
m
ily
 h
ist
or
y 
of
 H
PD
b
3 
(11
)
1.
91
 (0
.55
–6
.59
)
1.
21
1.
03
0.
30
M
ea
n 
(S
D)
O
R
 (9
5%
 C
I)
p-
va
lu
e
A
ge
 a
t i
nt
er
vi
ew
 (y
ea
rs)
24
.5
 (1
4.6
)
1.
02
 (1
.00
–1
.05
)
0.
01
2.
21
0.
03
TS
 a
ge
 o
f o
ns
et
 (y
ea
rs)
5.
6 
(3.
4)
0.
92
 (0
.80
–1
.08
)
0.
07
−
1.
00
0.
32
O
CD
 a
ge
 o
f o
ns
et
 (y
ea
rs)
6.
7 
(3.
4)
0.
96
 (0
.84
–1
.11
)
0.
07
−
0.
53
0.
60
Y
G
TS
S 
To
ta
l s
co
re
a
34
.9
 (9
.1)
1.
05
 (1
.01
–1
.11
)
0.
03
2.
25
0.
02
4
Y
G
TS
S 
M
ot
or
 sc
or
ea
19
.9
 (3
.8)
1.
16
 (1
.05
–1
.29
)
0.
06
2.
87
0.
00
4
Y
G
TS
S 
Ph
on
ic
 sc
or
ea
15
.0
 (6
.0)
1.
05
 (0
.97
–1
.12
)
0.
04
1.
20
0.
23
Y-
B
O
CS
 T
o
ta
l s
co
re
a
28
.8
 (7
.7)
1.
11
 (1
.03
–1
.19
)
0.
04
2.
84
0.
00
5
O
CD
=o
bs
es
siv
e-
co
m
pu
lsi
v
e 
di
so
rd
er
; A
D
H
D
=a
tte
nt
io
n-
de
fic
it/
hy
pe
ra
ct
iv
ity
 d
iso
rd
er
; T
S=
To
u
re
tte
 s
yn
dr
om
e;
 H
PD
=H
ai
r P
ul
lin
g 
D
iso
rd
er
; S
PD
=E
xc
or
ia
tio
n/
Sk
in
 P
ic
ki
ng
 D
iso
rd
er
; Y
G
TS
S=
Ya
le
 G
lo
ba
l 
Ti
c 
Se
v
er
ity
 S
ca
le
; Y
-
B
O
CS
=Y
al
e-
Br
ow
n
 O
bs
es
siv
e-
Co
m
pu
lsi
v
e 
Sc
al
e;
 S
D
=s
ta
nd
ar
d 
de
v
ia
tio
n;
a l
ife
tim
e 
w
o
rs
t-
ev
er
 s
co
re
s;
b I
nf
or
m
at
io
n 
on
 S
PD
 fa
m
ily
 h
ist
or
y 
no
t a
v
ai
la
bl
e.
Eur Child Adolesc Psychiatry. Author manuscript; available in PMC 2019 May 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Greenberg et al. Page 17
Table 3
Multivariable predictors of co-occurring HPD in TS patients
Predictor OR (95% CI) SE z p-value
Female sex 1.97 (0.81–4.80) 0.89 1.49 0.14
Age at Interview 1.02 (0.99–1.04) 0.01 1.21 0.23
Family history of TS/OCD 1.55 (0.61–3.94) 0.74 0.91 0.36
SPD 1.92 (0.72–5.15) 0.97 1.30 0.19
OCD 1.62 (0.58–4.52) 0.85 0.92 0.36
YGTSS Motor scorea 1.14 (1.00–1.28) 0.07 2.03 0.04
OCD=obsessive-compulsive disorder; ADHD=attention-deficit/hyperactivity disorder; TS=Tourette syndrome; HPD=Hair Pulling Disorder; 
SPD=Excoriation/Skin Picking Disorder; YGTSS=Yale Global Tic Severity Scale;
alifetime worst-ever score; n=731, LR χ2=17.9, p=0.006, pseudo-R2=0.09.
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Table 5
Multivariable predictors of co-occurring SPD in TS patients
Predictor OR (95% CI) SE z p-value
Female sex 2.08 (1.22–3.54) 0.56 2.70 0.007
OCD 4.32 (2.32–8.03) 1.37 4.63 3.7x10−6
ADHD 1.76 (1.07–2.88) 0.44 2.24 0.025
Age at Interview 1.00 (0.98–1.02) 0.01 −0.03 0.98
YGTSS Motor scorea 1.06 (1.001–1.13) 0.03 1.99 0.046
TS/OCD Family history 1.67 (0.997–2.79) 0.44 1.95 0.051
HPD 1.64 (0.57–4.70) 0.88 0.92 0.36
SPD=Excoriation/Skin Picking Disorder; OCD=obsessive-compulsive disorder. ADHD=attention-deficit/hyperactivity disorder; TS=Tourette 
syndrome; HPD=Hair Pulling Disorder; YGTSS=Yale Global Tic Severity Scale;
alifetime worst-ever score; n=710, LR χ2=67.0, p<0.00001, pseudo-R2=0.12.
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